PON3 and type 1 diabetes mellitus: A significant increase in PON3 concentrations has been reported in patients with chronic liver disease, HIV, and coronary and peripheral artery disease, although PON3 protein in HDL has been reported to decrease in autoimmune diseases such as lupus erythematosus and type 1 diabetes and in patients with subclinical atherosclerosis [26].